Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Understand the cash flow statement for Taysha Gene Therapies, Inc. (TSHA), learn where the money comes from and how the company spends it.

About Taysha Gene Therapies Inc. Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based ...

We currently have no TSHA Stock Split History on this stock.

Get the latest news and real-time alerts from Taysha Gene Therapies, Inc. (TSHA) stock at Seeking Alpha.